Chen Hongyi, Jorissen Robert, Walcott James, Nikfarjam Mehrdad
Department of Surgery, The University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
Systems Biology and Personalised Medicine Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
ANZ J Surg. 2020 Sep;90(9):1598-1603. doi: 10.1111/ans.15565. Epub 2019 Nov 19.
Acute cholecystitis (AC) is a surgical condition that is usually managed by emergency surgery. The presence of common bile duct stones (CBDS) in this setting mandates definitive treatment to avoid complications such as cholangitis. The incidence of CBDS in the setting of AC is poorly defined.
A systematic English literature search was conducted in PubMed, MEDLINE and Embase to determine the incidence of CBDS in patients presenting with AC. Outlier studies identified by funnel plot analysis were excluded and the incidence of CBDS was identified. The mean CBD diameter and liver function test values of patients with AC and CBDS were calculated.
Data were extracted from 19 studies representing a total 4057 patients with AC. Routine biliary imaging was not performed in all studies. The pooled incidence of CBDS was 13.7% (95% confidence interval 11.8-15.9). The incidence of unsuspected retained CBDS was 1.1%. Histologically confirmed cases of AC had a similar rate of CBDS compared to those diagnosed clinically. The mean CBD diameter of patients with AC and CBDS was 7.2 mm compared to 5.8 mm without. Liver function test values in the presence of CBDS were more likely to be deranged, with gamma-glutamyltransferase the most sensitive and specific marker for CBDS in the setting of AC.
CBDS is present in a significant proportion of patients presenting with AC. Routine biliary imaging is advised in all patients presenting with AC where possible.
急性胆囊炎(AC)是一种通常需通过急诊手术治疗的外科疾病。在此情况下存在胆总管结石(CBDS)时,必须进行明确治疗以避免诸如胆管炎等并发症。AC患者中CBDS的发生率尚不明确。
在PubMed、MEDLINE和Embase中进行系统的英文文献检索,以确定AC患者中CBDS的发生率。排除通过漏斗图分析识别出的异常研究,并确定CBDS的发生率。计算AC合并CBDS患者的胆总管平均直径和肝功能测试值。
从19项研究中提取数据,这些研究共纳入4057例AC患者。并非所有研究都进行了常规胆道成像。CBDS的合并发生率为13.7%(95%置信区间11.8 - 15.9)。未被怀疑的残留CBDS发生率为1.1%。组织学确诊的AC病例与临床诊断的病例相比,CBDS发生率相似。AC合并CBDS患者的胆总管平均直径为7.2mm,无CBDS患者为5.8mm。存在CBDS时肝功能测试值更可能出现异常,γ-谷氨酰转移酶是AC患者中CBDS最敏感和特异的标志物。
很大一部分AC患者存在CBDS。建议对所有可能的AC患者进行常规胆道成像。